India's Cipla, Sun get tentative FDA approvals (Reuters via Yahoo! Asia News)
MUMBAI, May 23 (Reuters) - Indian drug maker Cipla Ltd. has received tentative approval from the U.S. Food and Drug Administration for generic AIDS drug nevirapine in the tablet form, according to an FDA statement.

Teva to launch generic Zocor in June (Globes Online)
Leader: Revenue from the product will be $250 million in six months, and Teva will continue to fight the FDA over exclusivity.